DBV Technologies
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
DBVT Key Statistics
Stock Snapshot
The current DBV Technologies(DBVT) stock price is $18.37, with a market capitalization of 746.39M. The stock trades at a price-to-earnings (P/E) ratio of -3.50.
During the trading session on 2025-12-14, DBV Technologies(DBVT) shares reached a daily high of $19.85 and a low of $17.86. At a current price of $18.37, the stock is +2.9% higher than the low and still -7.5% under the high.
Trading activity shows a volume of 311.31K, compared to an average daily volume of 717.16K.
The stock's 52-week range extends from a low of $2.74 to a high of $21.50.
The stock's 52-week range extends from a low of $2.74 to a high of $21.50.
DBVT News
Cantor Fitzgerald analyst Kristen Kluska initiated coverage of DBV Technologies (DBVT) with an Overweight rating and $42 price target Claim 50% Off TipRanks Pr...